Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platform Construction and Clinical Application of 5G Technology for Remote Operation of the R-One™ Robot in Percutaneous Coronary Intervention

NCT07132255 is registered in ClinicalTrials.gov with Cathbot (Shanghai) Robot Co., Ltd as lead sponsor.

NCT NCT07132255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07132255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platform Construction and Clinical Application of 5G Technology for Remote Operation of the R-One™ Robot in Percutaneous Coronary Intervention
Lead sponsor
Cathbot (Shanghai) Robot Co., Ltd
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 14, 2024
Completion date
September 30, 2026
Enrollment
60 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad), percutaneous coronary intervention (pci)